NCT07761598Not yet recruiting
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 4 Aug 2026
- Start date
- Aug 2026
- Primary completion date
- Dec 2028
- Lead sponsor
- Jacobs institute
- Diseases
- Stroke
- NCT number
- NCT07761598
What you commit to
- Study type: Interventional
- Planned participants: 15
- From Aug 2026 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subject with anatomy not appropriate for endovascular treatment.
Who the study is looking for
- Subject has a single untreated target IA.
Age in the registry: 22 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Jacobs Institute Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.